Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party

Saved in:

Bibliographic Details
Published in:	Bone marrow transplantation (Basingstoke) Vol. 51; no. 9; pp. 1259 - 1261
Main Authors:	Koenecke, C, Heim, D, van Biezen, A, Heuser, M, Aljurf, M, Kyrcz-Krzemien, S, Volin, L, de Souza, C A, Gedde-Dahl, T, Sengeloev, H, Schanz, U, Komarnicki, M, Arroyo, C H, Tholouli, E, Gluckman, E, Esquirol, A, Yakoub-Agha, I, Gürman, G, Olavarria, E, Kröger, N
Format:	Journal Article
Language:	English
Published:	London Nature Publishing Group UK 01-09-2016 Nature Publishing Group
Subjects:	692/308/2779 692/499 Bone marrow Care and treatment Cell Biology Chronic myeloid leukemia Hematology Hematopoietic stem cell transplantation Hematopoietic stem cells Internal Medicine letter-to-the-editor Leukemia Medicine Medicine & Public Health Myeloid leukemia Patient outcomes Public Health Stem cell transplantation Stem Cells Transplantation
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1
ISSN:	0268-3369 1476-5365
DOI:	10.1038/bmt.2016.97